Al Kindi for Production of Veterinary Vaccines Drugs - ESG Rating & Company Profile powered by AI
Alternative companies in the rating peer group for Al Kindi for Production of Veterinary Vaccines Drugs are shown. Check the end of this webpage for potential risks for Al Kindi for Production of Veterinary Vaccines Drugs based on sector, geography and marketcap. This Disclosure rating covers seventeen United Nations SDGs including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Life below Water'.
Al Kindi for Production of Veterinary Vaccines Drugs in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Al Kindi for Production of Veterinary Vaccines Drugs | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Al Kindi for Production of Veterinary Vaccines Drugs have an accelerator or VC vehicle to help deliver innovation?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose current and historical energy intensity?
Does Al Kindi for Production of Veterinary Vaccines Drugs report the average age of the workforce?
Does Al Kindi for Production of Veterinary Vaccines Drugs reference operational or capital allocation in relation to climate change?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose its ethnicity pay gap?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose cybersecurity risks?
Does Al Kindi for Production of Veterinary Vaccines Drugs offer flexible work?
Does Al Kindi for Production of Veterinary Vaccines Drugs have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose the number of employees in R&D functions?
Does Al Kindi for Production of Veterinary Vaccines Drugs conduct supply chain audits?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Al Kindi for Production of Veterinary Vaccines Drugs conduct 360 degree staff reviews?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose the individual responsible for D&I?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose current and / or historical scope 2 emissions?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose water use targets?
Does Al Kindi for Production of Veterinary Vaccines Drugs have careers partnerships with academic institutions?
Did Al Kindi for Production of Veterinary Vaccines Drugs have a product recall in the last two years?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose incidents of discrimination?
Does Al Kindi for Production of Veterinary Vaccines Drugs allow for Work Councils/Collective Agreements to be formed?
Has Al Kindi for Production of Veterinary Vaccines Drugs issued a profit warning in the past 24 months?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose parental leave metrics?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose climate scenario or pathway analysis?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose the pay ratio of women to men?
Does Al Kindi for Production of Veterinary Vaccines Drugs support suppliers with sustainability related research and development?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Al Kindi for Production of Veterinary Vaccines Drugs reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Al Kindi for Production of Veterinary Vaccines Drugs involved in embryonic stem cell research?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose GHG and Air Emissions intensity?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose its waste policy?
Does Al Kindi for Production of Veterinary Vaccines Drugs report according to TCFD requirements?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose energy use targets?
Does Al Kindi for Production of Veterinary Vaccines Drugs disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Al Kindi for Production of Veterinary Vaccines Drugs have a policy relating to cyber security?
Have a different question?
Potential Risks for Al Kindi for Production of Veterinary Vaccines Drugs
These potential risks are based on the size, segment and geographies of the company.